Kui Luo

发表

An Engineered Butyrate-Derived Polymer Nanoplatform as a Mucosa-Healing Enhancer Potentiates the Therapeutic Effect of Magnolol in Inflammatory Bowel Disease.

Zhuangzhuang Zhang, Qingqing Pan, Yujie Pu, 2023, ACS nano.

Dendritic nanomedicine enhances chemo-immunotherapy by disturbing metabolism of cancer-associated fibroblasts for deep penetration and activating function of immune cells

Yahui Wu, Qiyong Gong, Dayi Pan, 2024, Acta pharmaceutica Sinica. B.

Triune Nanomodulator Enables Exhausted Cytotoxic T Lymphocyte Rejuvenation for Cancer Epigenetic Immunotherapy.

Lihuang Wu, Zhongwei Gu, Qingqing Pan, 2024, ACS nano.

A Double Network Composite Hydrogel with Self-Regulating Cu2+/Luteolin Release and Mechanical Modulation for Enhanced Wound Healing.

Qingqing Pan, Yujie Pu, L. Ye, 2024, ACS nano.

Two birds with one stone: copper metal-organic framework as a carrier of disulfiram prodrug for cancer therapy.

Qingqing Pan, Yujie Pu, Wenxia Gao, 2021, International journal of pharmaceutics.

Harnessing and Mimicking Bacterial Features to Combat Cancer: From Living Entities to Artificial Mimicking Systems.

Qiyong Gong, Zhenyu Duan, Jie Chen, 2024, Advanced materials.

Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy

Qiyong Gong, Zhongwei Gu, Zhiqian Li, 2024, Acta pharmaceutica Sinica. B.

A novel remnant liver-first strategy for liver autotransplantation in patients with end-stage hepatic alveolar echinococcosis: a retrospective case series

Tao Lv, Wan-Yee Lau, Jiu-Lin Song, 2023, International journal of surgery.

An olsalazine nanoneedle-embedded inulin hydrogel reshapes intestinal homeostasis in inflammatory bowel disease

Zhuangzhuang Zhang, Qingqing Pan, Zhaoyuan Guo, 2023, Bioactive materials.

Targeting lipid metabolism via nanomedicine: a prospective strategy for cancer therapy

Zhenyu Duan, Yinggang Li, Gang Xu, 2024, Biomaterials.